EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

EML4-ALK is found in the minority of NSCLC. ALK kinase inhibitors alone or in combination may nevertheless be clinically effective treatments for NSCLC patients whose tumors contain EML4-ALK.